Mod Rheumatol Case Rep. 2026 Mar 24:rxag025. doi: 10.1093/mrcr/rxag025. Online ahead of print.
ABSTRACT
Inclusion body myositis and immune-mediated necrotizing myopathy are inflammatory myopathies characterized by specific clinical and pathological features. Inclusion body myositis is associated with human immunodeficiency virus infection, whereas immune-mediated necrotizing myopathy is extremely rare in individuals positive for human immunodeficiency virus. To date, no reports have described the coexistence of immune-mediated necrotizing myopathy and inclusion body myositis-like pathological features in patients positive for human immunodeficiency virus. Herein, we report a rare case of a 40-year-old man with human immunodeficiency virus-associated subacute progressive myopathy presenting with simultaneous proximal and distal muscle weakness, dysphagia, and markedly elevated creatine kinase levels. Serological testing revealed strong positivity for anti-signal recognition particle antibodies. Muscle biopsy revealed coexisting pathological features suggesting both immune-mediated necrotizing myopathy and inclusion body myositis. The patient showed insufficient response to antiretroviral therapy and glucocorticoids; however, intravenous immunoglobulin therapy resulted in a marked clinical response. This case highlights the possible coexistence of immune-mediated necrotizing myopathy and inclusion body myositis-like pathology in the context of human immunodeficiency virus infection and provides insights into the pathophysiology of human immunodeficiency virus-associated myopathy. Furthermore, this report suggests the potential effectiveness of intravenous immunoglobulin treatment in such cases.
PMID:41874427 | DOI:10.1093/mrcr/rxag025
Share Evidence Blueprint
Save to Google Notes

Search Google Scholar
Save as PDF
⭐ My Revision List

